MedPath

To Evaluate the Efficacy of Sugammadex in Reversing the effect of a Muscle Relaxant in Patients Undergoing Major Upper Abdominal Surgery: An Observational Study

Not yet recruiting
Conditions
Medical and Surgical,
Registration Number
CTRI/2023/07/055172
Lead Sponsor
Dr. Ram Manohar Lohia Institute of Medical Sciences
Brief Summary

During general anesthesia muscle relaxants are given to faciliotate endotracheal intubation and for optimum surgical conditions. A complication may be post operative residual blockade during a prolonged surgical procedure. Intraoperatively Neuromuscular monitoring can be used to allow proper administration of the relaxant to decrease the incidence of post operative residual curarization. After the completion of the surgery we use a reversal agent as in this case, Sugammadex which has showed decreased incidence of the post operative complications related to residual blockade. Diaphragm Ultrasound (Thickening fractioning) and Neuromuscular monitoring (Train of Four ratio) will be the primary modalities we use to evaluate the efficacy of Sugammadex against the traditionally used reversal Neostigmine.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
50
Inclusion Criteria

ASA 1 and 2 Patients posted for major upper abdominal surgery.

Exclusion Criteria

Refusal to consent ASA 3, 4 and Emergency cases Patients with preoperative respiratory involvement BMI >30.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
To determine the time from administration of Sugammadex till extubation on the basis of Train of Four ratio 0.9After administration of Reversal agent
Secondary Outcome Measures
NameTimeMethod
To detremine the risk of post operative residual paralysis using diaphragm ultrasoundPreoperative baseline

Trial Locations

Locations (1)

Dr. Ram Manohar Lohia Institute of Medical Sciences

🇮🇳

Lucknow, UTTAR PRADESH, India

Dr. Ram Manohar Lohia Institute of Medical Sciences
🇮🇳Lucknow, UTTAR PRADESH, India
Dr Shilpi Misra
Principal investigator
9839932239
drshilpi1980@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.